Claire Villette has published an original research paper entitled “Semi-mechanistic efficacy model for PARP + ATR inhibitors—application to rucaparib and talazoparib in combination with gartisertib in breast cancer PDXs” in the British Journal of Cancer. You can read the publication here.

Congratulations!